TYYVYYT Trademark

Trademark Overview


On Thursday, November 12, 2020, a trademark application was filed for TYYVYYT with the United States Patent and Trademark Office. The USPTO has given the TYYVYYT trademark a serial number of 90315980. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2023. This trademark is owned by Eli Lilly and Company. The TYYVYYT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
tyyvyyt

General Information


Serial Number90315980
Word MarkTYYVYYT
Filing DateThursday, November 12, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 12, 2022SOU EXTENSION 2 FILED
Wednesday, October 12, 2022TEAS EXTENSION RECEIVED
Tuesday, April 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU EXTENSION 1 GRANTED
Tuesday, April 19, 2022SOU EXTENSION 1 FILED
Monday, April 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 19, 2022TEAS EXTENSION RECEIVED
Tuesday, November 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 24, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 24, 2021NON-FINAL ACTION E-MAILED
Saturday, April 24, 2021NON-FINAL ACTION WRITTEN
Friday, April 9, 2021ASSIGNED TO EXAMINER
Tuesday, January 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 16, 2020NEW APPLICATION ENTERED